The present study demonstrated that knockdown of PDCD10 in GBM cells led to a significant upregulation of EphB4 mRNA and protein expression and consequently a remarkable increase in the EphB4 kinase activity, which was completely reversed by the treatment with a specific EphB4 kinase inhibitor NVP. Here, EPHB4 is linked to glioblastoma.